Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Campbell

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
Science Translational Medicine|March 18, 2026
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletesChris Greene, Declan Brennan, Sheida Mirloo, et al.
Oncology and Therapy|July 24, 2020
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Tian Qi Wang, Joseph N Samuel, M Catherine Brown, et al.
Journal for Immunotherapy of Cancer|August 2, 2020
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinomaSara Bedrose, Kevin Charles Miller, Lina Altameemi, et al.
Nature Neuroscience|April 16, 2024
Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Screening metatranscriptomes for ultrastable RNA secondary structures reveals hidden bacteriophages and novel capsid nanomaterialsDaniel A Villarreal, Nino Makasarashvili, Aaryan Kapoor, et al.
Nature Neuroscience|February 22, 2024
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2024
Synergistic induction of blood-brain barrier propertiesGergő Porkoláb, Mária Mészáros, Anikó Szecskó, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Circulation|October 5, 2011
Wnt signaling mediates pathological vascular growth in proliferative retinopathyJing Chen, Andreas Stahl, Nathan M Krah, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Science Translational Medicine|March 18, 2026
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletesChris Greene, Declan Brennan, Sheida Mirloo, et al.
Oncology and Therapy|July 24, 2020
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Tian Qi Wang, Joseph N Samuel, M Catherine Brown, et al.
Journal for Immunotherapy of Cancer|August 2, 2020
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinomaSara Bedrose, Kevin Charles Miller, Lina Altameemi, et al.
Nature Neuroscience|April 16, 2024
Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Screening metatranscriptomes for ultrastable RNA secondary structures reveals hidden bacteriophages and novel capsid nanomaterialsDaniel A Villarreal, Nino Makasarashvili, Aaryan Kapoor, et al.
Nature Neuroscience|February 22, 2024
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2024
Synergistic induction of blood-brain barrier propertiesGergő Porkoláb, Mária Mészáros, Anikó Szecskó, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Circulation|October 5, 2011
Wnt signaling mediates pathological vascular growth in proliferative retinopathyJing Chen, Andreas Stahl, Nathan M Krah, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
Pageof 24